mln2480
Showing 1 - 2 of 2
Advanced Nonhematologic Malignancies Trial in Worldwide (MLN2480, MLN0128, Alisertib)
Completed
- Advanced Nonhematologic Malignancies
- MLN2480
- +5 more
-
Boston, Massachusetts
- +13 more
Feb 11, 2020